Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana
Thibang Diphatlha: Testing Adaptive Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana
Abramson Cancer Center at Penn Medicine
680 participants
Sep 1, 2023
INTERVENTIONAL
Conditions
Summary
Investigators will test the effectiveness of adaptive strategies on timely adoption of cervical cancer treatment in Botswana using a pragmatic trial design.
Eligibility
Inclusion Criteria7
- Patients will be eligible if they:
- are biological females
- are aged 18 or older
- have pathology-confirmed invasive cervical cancer diagnosis
- have pathology results evaluated at National Health Laboratory in Botswana
- are citizens of Botswana
- have no prior history of invasive cervical cancer
Exclusion Criteria3
- Patients will be excluded if they:
- are biological males or otherwise born without a cervix
- are below the age of 18 due to the rarity of cervical cancer in this population
Interventions
A member of the pathology team will contact the referring clinic to communicate the readiness of results.
A member of the pathology team will contact both the referring clinic and the patient directly to communicate the readiness of results.
Patient will be sent asynchronous text messaging reminders related to the importance of timely care using framed messaging.
Patient will be sent asynchronous text messaging reminders related to the importance of timely care using framed messaging in combination with synchronous telephone-based patient navigation.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05952141